193个联合国成员国育龄女性贫血干预措施的单位成本估算:一项成本核算研究
该成本核算研究采用微观成本法估算193个联合国成员国育龄女性六项WHO推荐的贫血预防和治疗干预措施的每接受者每年单位成本。在贫血负担最高的地区,主食强化和驱虫是成本最低的干预措施,多微量营养素补充剂平均单位成本最高。研究结果可促进育龄女性贫血干预措施的成本效果分析并加强优先级设置。
要点
- 采用微观成本法估算193个联合国成员国育龄女性六项贫血干预措施的单位成本。
- 在贫血负担最高的地区,主食强化和驱虫是成本最低的干预措施。
- 多微量营养素补充剂在多数国家平均单位成本最高。
核心结论
- 该标准化方法和数据集估算了国家层面单位成本并描述了WHO推荐的贫血干预措施的成本驱动因素,可促进育龄女性贫血干预措施的成本效果分析并加强优先级设置。
研究设计与样本
- 采用微观成本法,使用二手数据估算193个联合国成员国六项贫血预防和治疗干预措施的每接受者每年单位成本,采用卫生保健部门视角和1年时间范围,成本类别包括商品、供应链、服务提供和行政管理项目成本,参数不确定性通过确定性敏感性分析探讨,成本以2023年美元的人群加权均值和标准差表示。
主要发现
- 在多数国家,主食强化和驱虫是成本最低的干预措施,在贫血负担最高的地区人群加权平均成本低于每人每年1美元:低收入国家主食强化为0.27美元(SD 0.25),中低收入国家非孕妇驱虫为0.84美元(SD 0.21)。
- 多微量营养素补充剂在多数国家平均单位成本最高,低收入国家为9.57美元(SD 0.58),高收入国家为135.56美元(SD 25.95)。
- 商品和服务提供成本是最大的成本驱动因素,但因干预措施和地区而异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anaemia affects an estimated 1·92 billion people worldwide. The UN Sustainable Development Goals set targets for reducing anaemia prevalence by 50% in women of reproductive age, for whom the risks and consequences of anaemia are the greatest. Prioritisation of cost-effective anaemia reduction strategies relies on robust estimates of the costs of interventions. We aimed to develop country-specific unit cost estimates for WHO-recommended anaemia interventions for women of reproductive age. METHODS: A micro-costing approach was used to estimate unit costs (per recipient per year) for six anaemia prevention and treatment interventions in 193 UN member states using data from secondary sources. The interventions included were oral iron supplementation for pregnant and non-pregnant women, fortification of staple foods, multiple micronutrient supplementation for pregnant women, intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine, presumptive deworming treatment for pregnant and non-pregnant women, and insecticide-treated bednets. A health-care sector perspective and 1-year timeframe were adopted. Cost categories included commodity, supply chain, service delivery, and administrative programme costs. Parameter uncertainty was explored in deterministic sensitivity analyses. Costs are presented as population-weighted means and SDs in 2023 US dollars. FINDINGS: In most countries, staple food fortification and deworming were the lowest cost interventions, with population-weighted average costs of less than US$1 per person per year in settings with the highest burden of anaemia (ranging from $0·27 [SD 0·25] for staple fortification in low-income-countries to $0·84 [0·21] for deworming in non-pregnant women in lower-middle-income countries). Multiple micronutrient supplements had the highest average unit costs in most countries, with unit costs ranging from $9·57 (SD 0·58) in low-income countries to $135·56 (SD 25·95) in high-income countries. Commodity and service delivery costs were the largest cost drivers, although this varied across interventions and settings. INTERPRETATION: Our standardised methodology and dataset estimate country-level unit costs and describe cost drivers for WHO-recommended anaemia interventions. These findings can facilitate cost-effectiveness analyses of anaemia interventions for women of reproductive age and strengthen priority-setting processes. FUNDING: Gates Foundation.
引用
- Oliver VL, Wang Y, Leung S, et al. Estimated unit costs of anaemia interventions for women of reproductive age in 193 UN member states: a costing study. Lancet Haematol. 2025. PMID: 40882647. doi:10.1016/S2352-3026(25)00171-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。